Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4D | Q08499 | 2/20 | 0.53 |
| ▸ | PGR | P06401 | 1/20 | 0.53 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.53 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.53 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.53 |
| ▸ | HTR2B | P41595 | 1/20 | 0.53 |
| ▸ | MC3R | P41968 | 1/20 | 0.53 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.53 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | SAE1 | Q9UBE0 | 1/20 | 0.46 |
| ▸ | UBA2 | Q9UBT2 | 1/20 | 0.46 |
| ▸ | PTGFR | P43088 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.41 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.41 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1696535 | 1.00 | PDE4D (0.53) | PDE4DPGRADORA3ADRA2CSLC6A2 | |
| SCHEMBL15672955 | 1.00 | PDE4D (0.53) | PDE4DPGRADORA3ADRA2CSLC6A2 | |
| SCHEMBL15960983 | 0.91 | ALDH1A1 (0.55) | PDE4DPGRADORA3ADRA2CSLC6A2 | |
| SCHEMBL2738717 | 0.90 | ALDH1A1 (0.56) | PDE4DPGRADORA3ADRA2CSLC6A2 | |
| SCHEMBL15779594 | 0.90 | ALDH1A1 (0.56) | PDE4DPGRADORA3ADRA2CSLC6A2 | |
| SCHEMBL2738709 | 0.90 | ALDH1A1 (0.56) | PDE4DPGRADORA3ADRA2CSLC6A2 | |
| SCHEMBL14098071 | 0.90 | ALDH1A1 (0.56) | PDE4DPGRADORA3ADRA2CSLC6A2 | |
| SCHEMBL3439766 | 0.90 | ALDH1A1 (0.56) | PDE4DPGRADORA3ADRA2CSLC6A2 | |
| SCHEMBL12455915 | 0.90 | ALDH1A1 (0.56) | PDE4DPGRADORA3ADRA2CSLC6A2 | |
| SCHEMBL16509907 | 0.90 | ALDH1A1 (0.56) | PDE4DPGRADORA3ADRA2CSLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120088823-A1 | COMPOSITION AND METHOD FOR SCALP AND HAIR TREATMENT | R-TECH UENO, LTD. (JP) | 2012-04-12 | — | — | US | disclosed |
| US-20090298928-A1 | COMPOSITION AND METHOD FOR SCALP AND HAIR TREATMENT | R-TECH UENO, LTD. | 2009-12-03 | — | — | US | disclosed |
| US-20080033036-A1 | Composition and Method for Promoting Hair Growth | R-TECH UENO, LTD. (JP) | 2008-02-07 | — | — | US | disclosed |
| US-20070298134-A1 | Composition and Method for Scalp and Hair Treatment | R-TECH UENO, LTD. (JP) | 2007-12-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070298134-A1 | Composition and Method for Scalp and Hair Treatment | PTGER3, PTGDR2, HSD3B2 | PDE4D 977/4885PGR 333/4885ADORA3 2841/4885 |
| US-20120088823-A1 | COMPOSITION AND METHOD FOR SCALP AND HAIR TREATMENT | PTGER3, PTGDR2, HSD3B2 | PDE4D 977/4885PGR 333/4885ADORA3 2841/4885 |
| US-20090298928-A1 | COMPOSITION AND METHOD FOR SCALP AND HAIR TREATMENT | PTGER3, PTGDR2, HSD3B2 | PDE4D 977/4885PGR 333/4885ADORA3 2841/4885 |
| US-20080033036-A1 | Composition and Method for Promoting Hair Growth | COX15, PGF, PTGS2 | PDE4D 1937/4885PGR 324/4885ADORA3 3530/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.